Showing results (21-30 of 72) with videos related to

Sort By:
Pageof 8
Pharmacological Research|August 25, 2018
A PK/PD study of Delta-4 abiraterone metabolite in metastatic castration-resistant prostate cancer patientsBenoit Blanchet, Edith Carton, Mohammad Alyamani, et al.
Plos One|January 30, 2014
RNA control of HIV-1 particle size polydispersityCendrine Faivre-Moskalenko, Julien Bernaud, Audrey Thomas, et al.
Plos One|July 18, 2018
Establishing a mucosal gut microbial community in vitro using an artificial simulatorLinShu Liu, Jenni Firrman, Ceylan Tanes, et al.
Expert Opinion on Drug Metabolism & Toxicology|August 25, 2016
Clinical pharmacology, drug-drug interactions and safety of pazopanib: a reviewPascaline Boudou-Rouquette, Camille Tlemsani, Benoit Blanchet, et al.
Clinical Pharmacokinetics|August 11, 2018
Clinical Pharmacokinetics and Pharmacodynamics of DabrafenibAlicja Puszkiel, Gaëlle Noé, Audrey Bellesoeur, et al.
The Journal of Biological Chemistry|July 21, 2009
Physical and functional interaction between heterochromatin protein 1alpha and the RNA-binding protein heterogeneous nuclear ribonucleoprotein UMaya Ameyar-Zazoua, Mouloud Souidi, Lauriane Fritsch, et al.
Journal of Virology|May 29, 2015
Involvement of the Rac1-IRSp53-Wave2-Arp2/3 Signaling Pathway in HIV-1 Gag Particle Release in CD4 T CellsAudrey Thomas, Charlotte Mariani-Floderer, Maria Rosa López-Huertas, et al.
Bulletin Du Cancer|October 13, 2018
[Issues of oral targeted therapies in daily clinical practice: 5th edition of the congress of pharmacology of anticancer drugs]Sonia Zaibet, Charles Vauchier, Nihel Khoudour, et al.
Clinical Pharmacology and Therapeutics|March 20, 2025
Confirmatory Evidence Used in Non-Oncologic Rare Disease New Molecular Entity Marketing Applications Approved by FDA, 2020-2023Bridget M Nugent, Anuradha Ramamoorthy, Jennifer R Pippins, et al.
Pageof 8